Gene · 4050
Papers2,481
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 2,481
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| African Swine Fever Virus Infection and Cytokine Response In Vivo: An Update. | Viruses | 2023 | 36680273 | PubTator, text mining | PubMed |
| Exploring Mast Cell-CD8 T Cell Interactions in Inflammatory Skin Diseases. | Int J Mol Sci | 2023 | 36675078 | PubTator, text mining | PubMed |
| A Comprehensive Exploration of the Transcriptomic Landscape in Multiple Sclerosis: A Systematic Review. | Int J Mol Sci | 2023 | 36674968 | PubTator, text mining | PubMed |
| Both LTA and LTB Subunits Are Equally Important to Heat-Labile Enterotoxin (LT)-Enhanced Bacterial Adherence. | Int J Mol Sci | 2023 | 36674760 | PubTator, text mining | PubMed |
| Targeted therapy for head and neck cancer: signaling pathways and clinical studies. | Signal Transduct Target Ther | 2023 | 36646686 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing identifies a population of human liver-type ILC1s. | Cell Rep | 2023 | 36640314 | PubTator, text mining | PubMed |
| A multi-view latent variable model reveals cellular heterogeneity in complex tissues for paired multimodal single-cell data. | Bioinformatics | 2023 | 36622018 | PubTator, text mining | PubMed |
| Sorting Transcriptomics Immune Information from Tumor Molecular Features Allows Prediction of Response to Anti-PD1 Therapy in Patients with Advanced Melanoma. | Int J Mol Sci | 2023 | 36614248 | PubTator, text mining | PubMed |
| Tobacco-Based Vaccines, Hopes, and Concerns: A Systematic Review. | Mol Biotechnol | 2023 | 36528727 | PubTator, text mining | PubMed |
| Psoriatic arthritis: review of potential biomarkers predicting response to TNF inhibitors. | Inflammopharmacology | 2023 | 36508130 | PubTator, text mining | PubMed |
| Intratumoral tertiary lymphoid structures promote patient survival and immunotherapy response in head neck squamous cell carcinoma. | Cancer Immunol Immunother | 2023 | 36481914 | PubTator, text mining | PubMed |
| Single-cell RNA-seq analysis to identify potential biomarkers for diagnosis, and prognosis of non-small cell lung cancer by using comprehensive bioinformatics approaches. | Transl Oncol | 2023 | 36401966 | PubTator, text mining | PubMed |
| Stromal transdifferentiation drives lipomatosis and induces extensive vascular remodeling in the aging human lymph node. | J Pathol | 2023 | 36367235 | PubTator, text mining | PubMed |
| DNA methylation status of the SPHK1 and LTB genes underlies the clinicopathological diversity of non-alcoholic steatohepatitis-related hepatocellular carcinomas. | J Cancer Res Clin Oncol | 2023 | 36348017 | PubTator, text mining | PubMed |
| Myeloma immunoglobulin rearrangement and translocation detection through targeted capture sequencing. | Life Sci Alliance | 2023 | 36328595 | PubTator, text mining | PubMed |
| FBXW7β isoform drives transcriptional activation of the proinflammatory TNF cluster in human pro-B cells. | Blood Adv | 2023 | 36322817 | PubTator, text mining | PubMed |
| Distinct Mechanisms of Mismatch-Repair Deficiency Delineate Two Modes of Response to Anti-PD-1 Immunotherapy in Endometrial Carcinoma. | Cancer Discov | 2023 | 36301137 | PubTator, text mining | PubMed |
| Current Best Practice in Hepatitis B Management and Understanding Long-term Prospects for Cure. | Gastroenterology | 2023 | 36243037 | PubTator, text mining | PubMed |
| TWEAK-Fn14-RelB Signaling Cascade Promotes Stem Cell-like Features that Contribute to Post-Chemotherapy Ovarian Cancer Relapse. | Mol Cancer Res | 2023 | 36214671 | PubTator, text mining | PubMed |
| Peritumor tertiary lymphoid structures are associated with infiltrating neutrophils and inferior prognosis in hepatocellular carcinoma. | Cancer Med | 2023 | 36082777 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4050/papers?page=18